Rilpivirin
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1933/2024-SML | 18. 09. 2024 | GlaxoSmithKline, s.r.o. | 15 470 407,68 | 13 812 864,00 | 15 470 407,68 | 13 812 864,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| 01_Písemná zpráva zadavatele_Rilpivirin_EP.pdf | Písemná zpráva zadavatele | 25. 09. 2024 10:56 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| GlaxoSmithKline, s.r.o. | Praha | 15 470 407,68 | 13 812 864,00 | CZK | Yes |